Innovation Pharmaceuticals Inc (IPIX)

[Truthbythought]

While you wait...

Dr. Shapiro is involved in another little gem from Boston that is presenting Phase II results at the upcoming San Antonio Breast Cancer Conference and just put out a publication detailing the mechanism of action. For those that want to see the future of Kevetrin here today via the results of an advanced trial HSP90 inhibitor this is your chance. It should be pretty spectacular.

One clue, the company in question starts with an S and ends with an A.

Oh and I recently wrote an article about them. Check out their seeking alpha articles and look for a comparison to another well known cancer company. Hopefully you find it interesting and notice the similarities to Kevetrin (minus an extra HDAC inhibitor)

GLTA. This baby will turn a corner once they have a timeline on some results.